A Conserved Multi-Gene Family Induces Cross-Reactive Antibodies Effective in Defense against Plasmodium falciparum by Singh, Subhash et al.
A Conserved Multi-Gene Family Induces Cross-Reactive
Antibodies Effective in Defense against Plasmodium
falciparum
Subhash Singh
1¤*, Soe Soe
1, Simon Weisman
1,J o h nW .B a r n w e l l
2,J e a nL o u i sP e ´rignon
1, Pierre
Druilhe
1*
1Bio-medical Parasitology Unit, Institut Pasteur, Paris, France, 2Malaria Branch, Division of Parasitic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia,
United States of America
Abstract
Background: Two related merozoite surface proteins, MSP3 and MSP6, have previously been identified as targets of
antibody-dependent cellular inhibition (ADCI), a protective mechanism against Plasmodium falciparum malaria. Both MSP3
and MSP6 share a common characteristic small N-terminal signature amino-acid stretch (NLRNA/G), a feature similar to
MSP3-like orthologs identified in other human and primate malaria parasites.
Methods/Results: This signature amino-acid sequence led to the identification of eight ORFs contiguously located on P.
falciparum chromosome 10. Our subsequent investigations on their expression, localization, sequence conservation, epitope
sharing, immunogenicity and the functional role of antibodies in defense are reported here. Six members of P. falciparum
MSP3-multigene family share similar sequence organization within their C-terminal regions, are simultaneously expressed as
merozoite surface proteins and are highly conserved among parasite isolates. Each of these proteins is a target of naturally
occurring antibodies effective at parasite killing in ADCI assays. Moreover, both naturally occurring antibodies and those
generated by immunization display cross-reactivity with other members of the family and exhibit varied binding avidities.
Conclusions/Significance: The unusual characteristics of the MSP3 multi-gene family lead us to hypothesize that the
simultaneous expression of targets eliciting cross-reactive antibody responses capable of controlling parasite densities
could represent an immune process selected through evolution to maintain homeostasis between P. falciparum and human
hosts; a process that allows the continuous transmission of the parasite without killing the host. Our observations also have
practical consequences for vaccine development by suggesting MSP3 vaccine efficacy might be improved when combined
with the various C-terminus regions of the MSP3 family members to generate a wider range of antibodies acting and to
increase vaccine immunogenicity in varied human genetic backgrounds.
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Introduction
Naturally acquired immunity against the asexual blood stages of
human malaria is well-documented [1]. It is a state of immunity
against malaria, whereby immune effector mechanisms maintain
low densities of parasites and conversely chronic infection appears
necessary for long-term maintenance of effective clinical protec-
tion. Hence it has been named ‘‘premunition’’ in order to reflect
this incomplete effect and a delicately balanced equilibrium [2].
Passive transfers of immune sera to patients have demonstrated
that premunition is mediated by antibodies as IgG from clinically
immune individuals can control parasite density and disease
symptoms in recipients [3–6]. The same effect was obtained
against parasites from different geographical settings suggesting
conservation of the antigenic targets in different parasite strains.
AcarefulstudyofimmuneeffectorsagainstP.falciparum,andofthe
protective versus non-protective antibodies in one such passive
transfer experiment, led us to characterize the Antibody Dependent
Cellular Inhibition of parasite multiplication (ADCI) as a major
mechanism underlying premunition [7]. Indeed we found that IgG
from hyperimmune individuals inhibited P. falciparum growth in vitro
in co-operation with blood monocytes [8]. This ADCI effect,
validated by a clinical experiment, thereafter served as a functional
assay for the identification of the targets of protective IgG. A novel
antigen, Merozoite Surface Protein 3 (MSP3) was identified in this
manner by screening a P. falciparum genome-wide expression library
using ADCI [9]. In contrast to nearly all other malaria vaccine
candidates, the MSP3 C-terminal half showed complete sequence
conservation among .100 P.falciparum field isolates from different
geographical regions [9].
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further supported by results from a series of immuno-clinical field
studies, immunization of pre-clinical models and of volunteers in
clinical trials, with assessment of functional anti-parasite activity.
Seven studies in several field settings from Asia and Africa have
shown that anti-MSP3 antibodies, particularly belonging to the
IgG3 subclass, were strongly associated with acquired clinical
protection against malaria [10–14]. A human recombinant anti-
MSP3 antibody was found able to achieve parasite killing in co-
operation with monocytes at nanomolar concentrations [15].
Protection has been induced by MSP3 in primates challenged by
P.falciparum [16]. A phase-I MSP3 vaccine trial in 36 volunteers
elicited antibodies in humans that mediated efficient killing of P.
falciparum both in vitro and in vivo [17], and further Phase Ib studies
in African populations have confirmed the safety and immuno-
genicity of the formulation [18,19].
Subsequently, another Merozoite Surface Protein, called MSP6,
was identified with significant sequence similarities with MSP3
within its conserved C-terminal region. Antigenic domains within
the related C-terminal regions of MSP3 and MSP6 either shared
near complete sequence identity and cross-reactivity or limited
diversity with distinct antigenic properties both being targets of
naturally occurring antibodies capable of mediating parasite killing
[20]. Moreover, the C-terminal region of MSP6 is also highly
conserved in different parasite isolates.
Both MSP3 and MSP6 sequences show a small stretch of
amino-acids (NLRNA/G) immediately following their predicted
N-terminal signal sequence, a feature shared by MSP3 orthologs
identified from P. vivax and P. knowlesi, [21,22]. We therefore used
this small stretch of amino acids as ‘signature sequence’ in the N-
terminal region as a selection criterion and identified a series of
open reading frames located on chromosome 10 sharing an
organization of their C-terminal regions similar to that of MSP3.
In view of the vaccine potential of MSP3, particularly the
encouraging results obtained in the clinical vaccine trials, we
decided to investigate in detail the new members of this family
with respect to their expression, localization, sequence conserva-
tion, epitope sharing, immunogenicity and functional role of
antibodies in defense. Results shows that the MSP3-gene family
differs from other P. falciparum multi-gene families described so far
and suggest that the corresponding proteins play an important role
in eliciting protective antibody responses in humans. Based on
these results we formulate the hypothesis that the P. falciparum
MSP3-family of proteins could have the role of ensuring both host
and parasite survival leading to chronic infection without disease
symptoms.
Materials and Methods
Sequence analysis
The P. falciparum 3D7 genome database was searched using
GenBank BLAST at NCBI (http://www.ncbi.nlm.nih.gov/
Malaria/plasmodiumbl.html). All BLAST searches were done
without the low-complexity filter and with all other settings kept at
default. Pairwise homology was performed between different
protein sequences using Wilbur-Lipman algorithm, PAM 250
using the Gene Jockey II sequence analysis software. ClustalW was
used to produce the multiple alignments (http://www.ebi.ac.uk/
cgi-bin/newclustalwpl), which were copied into Boxshade Hof-
mann, Barron (at http://bioweb.pasteur.fr/seqanal.interfaces/
boxshade.html#letters) to produce the alignments. Prediction of
the signal peptides was done using iPsort and Signal P (at http://
hypothesiscreator.net/iPSORT/predict.cgi and http://www.cbs.
dtu.dk/services/signalp/#submission, respectively). Prediction
and analysis of coiled-coil regions from amino acid sequences
was performed with the COILS2.1 program [23]. Predictions of
two and three-stranded coiled-coil regions were performed with
the PAIRCOIL based MULTICOIL program [24]. Leucine
zipper predictions were based on the LZpred program [25] that
combines a coiled-coil prediction algorithm with an approximate
search for the characteristic leucine repeat. Regions of least
sequence relatedness among different members of the MSP3-
family of proteins were identified as ‘unique regions’ consisting of
50–80 residues (SI, Table 1A). The ‘unique regions’ did not show
significant relatedness to the amino-acid sequence of any other P.
falciparum protein in the database as analyzed through BLASTP
searches (‘score bit’ value to themselves in the BLAST was always
greater than 100 with ‘E values’ in the range of 9e-23 to 1e-40; a
few other hits obtained only against some of the ORFs
denominated MSP3.3, MSP3.4 and MSP3.5 were with a low
‘score bit’ value of less than 40 with ‘E values’ not less than 1e-04).
MSP3-family gene polymorphism analysis
Genomic DNA was isolated from 36 P. falciparum field isolates
obtained from different parts of the world: Brazil (B); Comoro
Islands (C); Dielmo, Senegal, West Africa (D) and Thailand (T),
using standard procedure, or commercially available kit (Qia-
gen). MSP3-family gene fragments were PCR amplified from
these DNA samples by using the primer pairs (SI, Table 1B). A
control (without template DNA) was included for each round of
PCR to ensure absence of PCR contamination. PCR amplicons
were purified by agarose gel electrophoresis, and sequenced
using standard dye-termination sequencing techniques. ClustalW
alignment of the predicted amino-acid sequence for each
member of the MSP3-family among different isolates is shown
(SI, Sequence conservation).
Cloning and expression of recombinant proteins
‘Unique region’ and ‘related carboxy-terminal’ gene fragments
were cloned from 3D7 strain genomic DNA and expressed and
purified as N-terminal His-tagged recombinant proteins. A set of
eight His-tagged recombinant proteins covering the unique regions
from each of the eight ORFs (MSP3.1u, MSP3.2u, MSP3.3u,
MSP3.4u, MSP3.5u, MSP3.6u, MSP3.7u and MSP3.8u) were
designed and expressed (Table S1). A set of six recombinant proteins
weredesignedtocovertherelatedC-terminalregionsofthesixgenes
showing substantial homology within their C-terminal regions, and
named MSP3.1-Ct, MSP3.2-Ct, MSP3.3-Ct, MSP3.4-Ct, MSP3.7-
Ct and MSP3.8-Ct (Table S2).
RNA analysis
RNA was extracted from asynchronous blood stage parasite
culture (3D7, harvested at 10–15% parasitemia) using TRIZOL
(Invitrogen), according to the manufacturer’s instructions. RNA
pellets were stored at 270uC. To ensure that RNA was completely
free of contaminating DNA, it was treated with DNaseI using DNA-
freekit(Ambion).First-strandofcDNAwassynthesized fromaround
1 mg of DNA-free RNA using a set of random primers and M-MLV
Reverse transcriptase (Invitrogen) following the supplier’s instruc-
tions. Amplification of the unique regions of MSP3-family of genes
was done using the set of primers listed in Table S1. Controls
consisting of genomicDNAastemplateand nonucleicacid(wateras
template) were included for each primer pair.
Western blot and dot-blot assays
Western blot analysis was performed against parasite proteins
resolved on a 12% SDS-PAGE under denaturing conditions using
MSP3 Multigene Family
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were performed using purified recombinant proteins on strips of
nitrocellulose paper (Amersham). In order to obtain comparable
protein distribution of proteins in each dot sample, both the
concentration and volume was adjusted. Typically 2 mg of purified
recombinant protein in 10 ml was applied to the nitrocellulose
membrane using a vacuum manifold (BioRad). Dot-blots were
processed for antibody signal detection similar to the Western blot
strips.
Indirect Immunofluorescence Assay (IFA)
IFA was performed on air-dried, acetone-fixed, thin smears of P.
falciparum mature schizonts. IFA was used to detect subcellular
localization of proteins and to adjust the functional concentration
of the affinity-purified antibodies for use in ADCI assays, as
described elsewhere [12].
ELISA
ELISA assays were performed for the detection of total IgG
and subclasses, as described elsewhere [27] in a pool of
hyperimmune sera against different members of the MSP3-
family of proteins. Sera from mice immunized with MSP3.1-Ct
and MSP3.2-Ct recombinant proteins were also tested for their
ability to cross-react with other members of the MSP3-family.
The specific reactivity of each serum sample (human/mouse)
was obtained by subtracting the optical density value of a control
protein (0.25 mg of bovine serum albumin/well) from that of the
test antigens.
Affinity purification of antibodies
Antibodies were affinity-purified against different members of
the MSP3-family of proteins from a pool of hyperimmune sera
obtained from the inhabitants of the village of Dielmo, Senegal,
West Africa. Affinity purification was done as described elsewhere
[12] using purified recombinant protein adsorbed on the surface of
polystyrene beads (mean diameter, 10 mm; Polysciences). Specific
antibodies were eluted by use of 0.2 M glycine (pH 2.5) and were
immediately neutralized to pH 7.0 using 2 M aqueous Tris-base.
Affinity-purified antibodies were dialyzed extensively against PBS
followed by RPMI and were concentrated using Centricon
concentrators (Millipore), filter sterilized, and, after addition of
1% Albumax (Invitrogen), stored at 4uC.
Cross-reactivity studies
The degree of antigenic relatedness between the different
carboxy-terminal recombinant proteins from members of the
MSP3 family of proteins was assessed by testing the cross-reactivity
of antibodies generated against each recombinant protein. To test
the existence of antigenic relatedness among different members of
the MSP3 family of proteins, ELISA assays were performed using
antibodies affinity-purified from hyperimmune sera at a concen-
tration of 10 mg/ml. Cross-reactivity of mice sera generated
against MSP3.1-Ct and MSP3.2-Ct recombinant proteins were
tested against other members of the MSP3-family of proteins by
performing ELISA, using 1:50 dilution of the mice sera.
Avidity studies
Antibody binding avidity was determined for naturally
occurring human antibodies against the C-terminal recombinant
proteins from MSP3-family members using dot-blot assay.
Identical strips of nitrocellulose membranes arrayed with equal
amount of recombinant proteins were tested for residual
antibody binding after no treatment or treatment with increasing
concentrations of chaotropic salt (NH4SCN: 0.1 M, 0.25 M,
0.62 M, 1.56 M and 3.9 M) for 20 min at room temperature.
Values obtained for the antibody reactivity against any antigen
in presence of no NH4SCN salts was considered to be 100%,
and the residual antibody reactivity after treatment with higher
concentrations of NH4SCN salts was expressed as fractions of
this 100%. Quantitative assessment of antibody reactivity was
done by Adobe Photoshop based image analysis after scanning
the dot-blots using EPSON scanner (model: EU34; EPSON
TWAIN software). The image was analyzed with Adobe
Photoshop software (version 6, Adobe Systems) using a
Macintosh PowerPC G4 system. Briefly, a fixed pixel area was
selected from the nitrocellulose membrane containing both the
‘‘dot-staining’’ due to the antibody reactivity together with a
portion of ‘‘background’’ (surrounding unstained nitrocellulose
membrane). This pixel-area was saved using the ‘‘save selection’’
option (Select-menu) and was used to generate histograms
(Image-menu). The histograms were set to display statistical
details of the selected pixel area in the ‘‘luminosity’’ channel.
The ‘‘Std Dev’’ value in the histogram represented the level of
contrast between the bright areas (nitrocellulose background)
and the dark area (staining due to antibody reaction), and was
used for comparing the levels of residual antibody reactivity.
Functional in vitro antibody assays
The antibody-dependent, monocyte-mediated ADCI assays
were performed in duplicate by use of laboratory-maintained
strains 3D7 and Uganda Palo-Alto, as described elsewhere [28].
Briefly, monocytes from healthy, non–malaria-exposed donors
were prepared as described elsewhere [28]. The affinity-purified
antibodies, adjusted to a concentration yielding a 1/200 IFA end-
point titer, were added at a rate of 10 mLi n9 0mL of complete
culture medium, which yielded a final titer of 1/20 in the ADCI
assay. After cultivation for 96 h, the level of parasitemia was
determined on Giemsa-stained thin smears from each well by the
microscopic examination of 50,000 erythrocytes. Monocyte-
dependent parasite inhibition is expressed as the specific growth
inhibition index (SGI): SGI=1-([percentage of parasitemia with
monocytes and test IgG/percentage of parasitemia with test IgG)/
(percentage of parasitemia with monocytes and normal IgG/
percentage of parasitemia with normal IgG]). A positive control
IgG, from the pool of serum samples from Ivory Coast used for
passive-transfer experiments in humans [6] and a negative control
IgG, from French donors who were never exposed to malaria
infection, were included in the assay.
Results
Identification of six MSP3 paralogs located in tandem on
Chromosome 10
Based on the signature motif (NLRNA/NLRNG) in the N-
terminal region of MSP3, MSP6, and of multi-allelic orthologs of
MSP3 from other species [21], our search for MSP3 paralogs in P.
falciparum genome (http://www.ncbi.nlm.nih.gov/Malaria/
plasmodiumbl.html) identified a contig of 32 kb on chromosome
10, with 8 ORFs located contiguously on the same coding strand
(Fig. 1A). The PlasmoDB (http://www.plasmodb.org/plasmo/
home.jsp) gene IDs for these ORFs are: PF10_0345 (MSP3),
PF10_0346 (MSP6), PF10_0347 (H101), PF10_0348 (hypothetical
protein), PF10_0350 (hypothetical protein), PF10_0351 (hypothet-
ical protein), PF10_0352 (H103) and PF10_0355 (hypothetical
protein), with known genes GLURP (PF10_0344) and LSA-1
(PF10_0356) flanking on the 59 and 39 sides of this cluster,
respectively. All of these ORFs have an N-terminal signal peptide
MSP3 Multigene Family
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contiguous location of these eight ORFs on the same chromosome
is suggestive of gene duplication events with subsequent diver-
gences as a possible mechanism for evolution of this gene family.
All of these eight ORFs retain the N-terminal MSP3-signature
motif, while six of these also display striking sequence relatedness
in their C-terminal regions (<32% identity and <54% similarity
of amino acid residues, Fig. 1, Fig. 2 and Table 1), marked by a
glycine-rich motif and followed by an acidic region and a coiled-
coil region, together with domains which have been identified as
targets of protective antibodies in MSP3 [12] and MSP6 [20], as
shown in Fig. 1B. Based on their sequence relatedness we propose
to group these ORFs as MSP3-multigene family in P. falciparum,
and rename them in the order of their location on the
chromosome with previously described members: MSP3 becoming
MSP3.1, MSP6 renamed MSP3.2, H101 renamed MSP3.3, H103
renamed MSP3.7 and the remaining being MSP3.4, MSP3.5,
MSP3.6, and MSP3.8. Of these eight ORFs, two of them, MSP3.5
and MSP3.6, shall be distinguished as they do not share relatedness
to other members of the family in their C-terminal regions (Fig. 2),
and are therefore described separately in the following analysis.
In contrast to the similarities observed within the C-terminus
regions of the six main members of the family, the N-terminal
regions of these ORFs show high level of sequence divergence
from one gene to the other. Two of these, MSP3.4 and MSP3.8,
include a DBL-like cysteine-rich domain, similar to those observed
in members of the var or ebl gene families (Fig. 2), which suggests a
possible role in interaction with erythrocytes. The characteristic
MSP3.1 heptad repeats and MSP3.7 proline-rich region also
suggest protein-protein interaction roles for these domains.
High degree of sequence conservation of the C-terminal
regions of the 6 genes
As the C-terminal region of MSP3 is characterized by an
unusually high degree of sequence conservation, this feature was
investigated in the remaining five ORFs. Sequence analysis of the
related C-terminal regions in thirty-six P. falciparum isolates
revealed a remarkably high degree of intra-species amino acid
sequence conservation (.95%) among parasite isolates of various
geographical origins (Text S1). This high degree of sequence
conservation is quite unusual among P. falciparum genes coding for
surface antigens and, therefore suggests an unknown but strong
functional importance of these domains in the parasite biology.
Figure 1. Panel (A): Schematic presentation of a 32 kb contig located
on P. falciparum Chromosome 10 (1404403 to 1436403 bp of the 3D7
strain) indicating the relative positions of the MSP3-like ORFs. MSP3.1
and MSP3.2 are genes known to encode merozoite surface proteins
MSP3 and MSP6, respectively. Panel (B): ClustalW alignment and
Boxshade representation of the amino acid sequences of the MSP3-
family of proteins with related C-terminal sequence organization.
MSP3.5 and MSP3.6 do not share the C-terminal sequence similarities
with other members. Identical residues are indicated by white letters on
black backgrounds, whereas similar residues are indicated by black
letters on a gray background. Dashes represent gaps to optimize
alignments. The pattern shared by MSP3-family members are: the N-
terminal signal-peptide (dotted line-box); the signature sequence of the
MSP3 family of proteins [1]; the glutamic acid rich region [2]; and the
leucine-zipper domain [3]. Sequences highlighted in black are related to
regions identified as targets of protective antibodies identified in
MSP3.1. Panel (C): A cladogram showing sequence analogy between
different MSP3-like ORFs derived by comparing the encoded protein
sequences.
doi:10.1371/journal.pone.0005410.g001
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We analyzed the expression of the MSP3-multigene family in P.
falciparum 3D7 strain, both at RNA and protein level. To this end,
‘‘unique regions’’ (70–80 amino acids stretches chosen as having
the least relatedness with the remaining members of the MSP3-
family and with other P. falciparum proteins, as verified by
BLASTP-analysis) were identified within each ORF, as shown in
Fig. 2, and used to analyze transcription and expression.
PCR analysis of cDNA prepared from asynchronous asexual
parasite culture using unique region primer sets (Table S1) showed
RNA expression for all six MSP3-family members (Fig. 4, panel
A).
To test protein expression, these unique regions were also
expressed as His-tagged recombinant proteins in E. coli (Fig. 2, and
Table S1). Then antibodies from African hyperimmune sera were
affinity-purified against the unique region recombinant proteins,
as described elsewhere [12]. The specificity of antibodies affinity-
purified against each unique region recombinant was established
by testing its reactivity against the unique regions from the
remaining MSP3-family members, and against other blood stage
proteins expressed in P. falciparum using protein blots (Fig. 3).
Figure 2. Schematic presentation of the protein sequences encoded by MSP3-like ORFs.
doi:10.1371/journal.pone.0005410.g002
Table 1. BLASTP comparison of the P. falciparum MSP3 family of proteins.
Gene product E value (% identity, % similarity)
MSP3.1 MSP3.2 MSP3.3 MSP3.4 MSP3.7 MSP3.8
MSP3.1 0.0 9610
241 (31,48) 3610
221 (26,42) 3610
221 (26,48) 8610
224 (25,40) 2610
217 (25,41)
MSP3.2 8610
241 (31,48) 0.0 1610
221 (30,47) 2610
223 (27,45) 7610
229 (26,43) 9610
223 (31,51)
MSP3.3 9610
227 (26,42) 9610
222 (30,47) 0.0 1610
217 (32,51) 2610
220 (25,41) 1610
217 (27,45)
MSP3.4 1610
221 (26,48) 1610
224 (27,45) 5610
218 (32,51) 0.0 2610
217 (31,52) 1610
292 (31,47)
MSP3.7 7610
224 (25,40) 3610
229 (26,43) - 3610
217 (31,52) 0.0 9610
212 (25,40)
MSP3.8 7610
219 (25,41) 2610
223 (31,51) 1610
218 (27,45) 6610
293 (31,47) 2610
212 (25,40) 0.0
The sequences indicated in bold were used as queries in a custom blast at the Malaria Genetics/Genomic database at NCBI.
doi:10.1371/journal.pone.0005410.t001
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parasite protein was performed using antibodies affinity-purified
against each unique region recombinant protein (Fig. 4, panel B).
The expression of the native parasite protein was confirmed for the
six ORFs with related C-terminal region. Though the observed
molecular weights of the parasite proteins were mostly in
agreement with their calculated molecular weights, in few cases
like in MSP3.1 the observed molecular weight (<48 kDa) was
higher than the calculated molecular weight (<40 kDa), which is
in keeping with previous observations [29]. Lower molecular
weight proteins, recognized by some affinity-purified antibodies,
could be due to the proteolytic processing of the nascent protein as
known in the case of MSP3.2 [30], or degradation products.
Previous studies have demonstrated the merozoite surface
localization for MSP3.1 and MSP3.2 [9,20]. Using antibodies
affinity-purified against the unique regions, we assessed the
localization of other members of the family in maturing
schizonts and released merozoites of P. falciparum 3D7 strain,
through IFA (Fig. 4, panel C). Antibodies against all the six
ORFs with related C-terminal region stained the surface of free
merozoites, showing a pattern indistinguishable from that
observed for MSP3.1 or MSP3.2. This pattern of IFA reactivity
was further confirmed in two other laboratory strains, Uganda
Palo-Alto and T23 (data not shown). Each of the parasites
examined under several microscopic fields showed fluorescent
labeling when stained by antibodies against unique regions of
different members, indicating consistent expression of the six
proteins in all individual parasites.
Among the two ORFs, which did not share the C-terminal
relatedness, i.e. MSP3.5 and MSP3.6, RNA expression was also
detected. However, the low level of cDNA amplification observed
for MSP3.5 suggests lower stability of the corresponding transcript
(Fig. 4, panel A, top right). Furthermore, antibodies affinity-
purified against MSP3.5u and MSP3.6u recombinant proteins did
not recognize specific parasite proteins. Whereas anti-MSP3.5
antibodies did not react to any parasite protein, anti-MSP3.6u
antibodies reacted to several polypeptides, which did not match its
calculated molecular weight of 65 kDa (Fig. 4, panel B). Anti-
MSP3.5u antibodies also failed to react to the parasite protein by
IFA (Fig. 4, panel C, top right). It is likely that owing to its less
stable transcript, MSP3.5 is not expressed in the erythrocytic stage.
Anti-MSP3.6u antibodies reacted to mature schizonts and free
merozoites (Fig. 4, panel C). However, since anti-MSP3.6u
antibodies displayed obvious cross-reactivities to several parasite
proteins in Western blot analysis, its expression remains to be
investigated in greater detail. These results confirm that these two
ORFs differ markedly from the other six.
Conversely, results from RNA and protein expression analysis,
together with cellular localization studies demonstrate that the six
MSP3-family members with C-terminal relatedness are all
expressed in the erythrocytic stage of parasite development as
merozoite surface proteins, thus, constituting the MSP3-family of
proteins in P. falciparum asexual blood stage development.
A network of cross-reactivity among MSP3-family
members is displayed by naturally occurring or
immunization-induced antibodies
The striking similarities in sequence organization observed
between the C-terminal halves of the MSP3-family members
together with limited diversity observed for the regions identified
as targets of parasite killing antibodies in MSP3.1 and MSP3.2
(Fig. 1B), led us to investigate the antigenic relatedness between
these proteins. The related C-terminal half of each member was
expressed as recombinant His-tag proteins in E. coli (Table S2). A
Figure 3. Specificity of antibodies affinity-purified against recombinant proteins covering the ‘unique-regions’ identified in each
member of the MSP3-like ORFs. 2 mg of the purified His-tag recombinant protein (MSP3.1u,….MSP3.8u) was dot blotted on nitrocellulose strips.
Antibodies affinity-purified against each unique region recombinant protein, from hyperimmune sera (anti-MSP3.1u,….anti-MSP3.8u), were tested
against a panel of all unique region recombinant proteins, as shown in the figure above. The pattern of antibody reactivity shows high specificity of
the affinity-purified antibodies towards the recombinant proteins against which they were affinity-purified.
doi:10.1371/journal.pone.0005410.g003
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distinct levels of reactivity against the six C-terminal recombinant
proteins (Fig. 5). The patterns of IgG subclass distribution against
each recombinant protein indicated differences in their antigenic
characteristics.
Human antibodies affinity-purified against each of the C-
terminal recombinant proteins were found to display varying
degrees of cross-reactivity with the remaining members of the
family, as determined by ELISA (Table 2). While anti-MSP3.1-Ct
antibodies exhibited the lowest extent of cross-reactivity to other
members of the family, MSP3.1-Ct itself appeared to be the target
most widely recognized by antibodies affinity-purified on other
members of the family. The opposite situation was found for
MSP3.4-Ct. Although anti-MSP3.4-Ct antibodies displayed the
highest level of cross-reactivity to other members of the family,
MSP3.4-Ct itself was less well recognized by antibodies affinity-
purified on other members. Antibodies against the remaining
members of the family displayed intermediate levels of cross-
reactivity. None of the naturally occurring antibody preparation
affinity-purified against the C-terminal recombinants displayed
reactivity against a set of negative control antigens which included
unrelated recombinant malaria antigen DG571-His and BSA.
In order to better characterize the above cross-reactivities, the
binding avidity of the affinity-purified antibodies was investigated
by ELISA under increasing concentrations of the chaotropic ion,
ammonium thiocyanate (NH4SCN). Various patterns of avidity
were observed for each affinity-purified antibody against different
members of the family. Moreover, for several antigen-antibody
combinations, the multiple slopes observed indicate a mix of
antibody species with distinct binding avidities (an example is
shown in Fig. 6). The area under the curve (AUC) was used to
estimate the overall binding avidity of these heterogeneous
populations of naturally occurring antibodies for the different
MSP3-family members. The summation of the AUCs in turn
allowed an estimation of ‘‘antigenicity’’ (the ability of any MSP3-
family protein to be recognized by antibodies against other family
proteins), and of ‘‘cross-reactivity’’ (the reactivity of protein-
specific antibodies with other MSP3 proteins). In Figure 7,
‘antigenicity ranking’ is obtained by summation along the
columns, whereas the ‘cross-reactivity ranking’ is obtained by
Figure 4. Expression analysis of MSP3-like ORFs. Panel A: Transcript analysis by RT-PCR. Arrowheads indicate the size of the cDNA amplification
obtained using primer sets specific for each ORF. Note that the transcript for MSP3.5 was less abundant as compared to other members of the family.
Panel B: Detection of protein encoded by different MSP3-like ORFs in P. falciparum 3D7 blood stage extract, by Western blot analysis, using
antibodies affinity-purified against unique non cross-reactive region identified in each ORF. Arrowheads indicate the size of the P. falciparum protein
detected by denaturing SDS-PAGE. The numbers represent positions of the molecular weight markers. Antibodies affinity-purified against unique
regions of MSP3.5 and MSP3.6 did not detect specific protein products in the parasite extract. Panel C: IFA analysis of acetone-fixed thin smear of the
blood stage parasites, using the same antibodies used for Western blot analysis, shows merozoite surface staining. The size-bar drawn in the lower
right-hand corner of each microscopic field represents 5 mm. Antibodies affinity-purified against the unique region of MSP3.5 did not react to parasite
proteins in IFA.
doi:10.1371/journal.pone.0005410.g004
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MSP3.1-Ct was found to be the ‘most antigenic’ and MSP3.4-Ct
the ‘least antigenic’. Anti-MSP3.1-Ct antibodies were found to be
the least cross-reactive, whereas anti-MSP3.4-Ct and anti-
MSP3.2-Ct antibodies were the most cross-reactive. These results
suggest that a complex network of cross-reactivity exists amongst
naturally occurring antibodies against different members of the
MSP3 family of proteins.
Immunization of mice with MSP3.1-Ct and MSP3.2-Ct
recombinant proteins also generated antibodies cross-reactive to
other members of the MSP3-family (Fig. 8). In contrast to the low
degree of cross-reactivity displayed by naturally occurring anti-
MSP3.1-Ct antibodies, immunization of mice generated anti-
MSP3.1-Ct antibodies which displayed a wider pattern of cross-
reactivity, i.e. comparable to that of anti-MSP3.2-Ct antibodies.
The differences between the fine specificity of antibody resulting
from natural exposure of from artificial immunization deserve
further investigations. It is however, encouraging for vaccine
development to note that the network of antibody cross-reactivity
amongst the MSP3-proteins, which develops through natural
exposure, can be mimicked by antibodies elicited by artificial
immunization.
The 6 MSP3-proteins are targets of antibodies effective in
ADCI
Anti-MSP3.1-Ct and anti-MSP3.2-Ct antibodies were found
earlier to mediate the monocyte dependent inhibition of P.
falciparum growth [19,20]. Antibodies affinity-purified from hyper-
immune sera against the C-terminal regions of the six related
members of the MSP3-family, were adjusted to an equal effective
concentration, i.e. yielding the same reactivity to the native
parasite protein as determined by IFAT. Affinity-purified
antibodies against each MSP3-family member were found able
to mediate a strong monocyte dependent parasite inhibition in
ADCI assay in vitro (Fig. 9). The inhibition levels were of
magnitude similar to that obtained using the pool of African
Figure 5. Pattern of antibody subclass reactivity observed against different members of the MSP3-family of proteins in a pool of
hyperimmune sera from malaria endemic village Dielmo, Senegal. The histograms represent mean O.D.450 values obtained after subtracting
the reactivity against BSA.
doi:10.1371/journal.pone.0005410.g005
Table 2. Naturally occurring antibodies against related C-terminal regions of the MSP3 family of proteins exhibit cross-reactivity.
MSP3.1-Ct MSP3.2-Ct MSP3.3-Ct MSP3.4-Ct MSP3.7-Ct MSP3.8-Ct DG571-His BSA
anti-MSP3.1-Ct 0.156 (100%) 0.009 (5.8%) 0.052 (33.3%) 0.007 (4.5%) 0.054 (34.6%) 0.036 (23.1%) 0.005 (3.2%) 0.006 (3.8%)
anti-MSP3.2-Ct 0.073 (54.5%) 0.134 (100%) 0.029 (21.6%) 0.005 (3.7%) 0.052 (38.8%) 0.05 (37.3%) 0.005 (3.7%) 0.006 (4.5%)
anti-MSP3.3-Ct 0.135 (117.4%) 0.052 (45.2%) 0.115 (100%) 0.006 (5.2%) 0.115 (100%) 0.054 (47.0%) 0.006 (5.2%) 0.006 (5.2%)
anti-MSP3.4-Ct 0.158 (216.4%) 0.032 (43.8%) 0.095 (130.1%) 0.073 (100%) 0.107 (146.6%) 0.075 (102.7%) 0.007 (9.6%) 0.007 (9.6%)
anti-MSP3.7-Ct 0.047 (32.0%) 0.006 (4.1%) 0.005 (3.4%) 0.005 (3.4%) 0.147 (100%) 0.007 (4.8%) 0.006 (4.1%) 0.006 (4.1%)
anti-MSP3.8-Ct 0.085 (72.6%) 0.027 (23.1%) 0.031 (26.5%) 0.009 (7.7%) 0.062 (53.0%) 0.117 (100%) 0.007 (6.0%) 0.006 (5.1%)
Antibodies affinity-purified against C-terminal recombinant protein from each member of MSP3-family of proteins were assessed for their cross-reactivity towards other
members by ELISA. O.D.450 values obtained for the reactivity of affinity-purified antibodies towards each recombinant protein are shown. The shaded boxes represent
reactivity of the antibodies affinity-purified against their respective recombinant proteins, which was considered to be 100%. The degree of cross-reactivity towards
other members of the family is expressed as fractions of 100%, shown in bold.
doi:10.1371/journal.pone.0005410.t002
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demonstrate that each member of the MSP3-family of proteins
serves as a target for naturally occurring antibodies with anti-
parasite effect, which is in accordance with their sequence
similarities and the network of cross-reactivity displayed by
antibodies against them.
Discussion
In the present work, we have characterized a new multi-gene
family coding for six merozoite surface proteins that share the
same structural organization of their C-terminal regions and have
attractive immunological features. These genes are located
contiguously on the same locus of chromosome 10, and share
the NLRNA/NLRNG signature motif [21] besides homologous
C-terminal regions. These C-terminal regions bear particular
importance. Although they show considerable divergence between
one paralog and any of the others, yet each paralog is remarkably
well-conserved from one isolate to another and in the process
share epitopes that generate a wide network of cross-reactive
antibodies with all six members being the targets of antibodies
mediating parasite killing through ADCI.
Four members of the P. falciparum MSP3-family, MSP3.1,
MSP3.2, MSP3.3 and MSP3.7 (originally described as MSP3,
MSP6, H101 and H103 respectively), had been previously
identified as merozoite surface proteins [9,30,31]. The family is
actually made of eight ORFs, which had been detected previously
through P. falciparum genome analysis [32], but among which we
were led to exclude two ORFs because they do not share the same
C-terminus organization, have absent or unstable transcription
and debatable protein expression. We therefore propose to group
the remaining six MSP3-related proteins based on their sequence
relatedness and antigenic cross-reactivity as constituting the P.
falciparum MSP3 family of proteins.
This family has similarities with the MSP3 orthologs described
in different malaria parasite species such as P. knowlesi and P. vivax
in which multi-allelic homologs have been described
[21,22,40,41], as is now the case for P. falciparum. All known
MSP3-orthologs across different species are characterized by the
N-terminal signature motif present shortly after the predicted
signal peptide sequence [21]. However, although they do share the
same similar structural organization in their C-terminal regions
between species and paralogs, and are as well-conserved from one
isolate to the other [42,43] as we find in P. falciparum, the P. knowlesi
and P. vivax MSP3 orthologs also markedly differ from the six P.
falciparum MSP3 genes. Each of the MSP3 orthologs and paralogs
in P. vivax and P. knowlesi have an extensive central alanine-rich
coiled-coil domain similar to the shorter coiled-coil region found
only in the P. falciparum MS3.1 paralog. All other P. falciparum
family members have in each other, ‘unique’ domains that are
very different from one another.
The P. falciparum MSP3-multigene family differs from other
known P. falciparum gene families expressed during the develop-
ment of asexual blood stages. Members of the antigenic variation
super gene families such as the var, rifin and stevor, which show
multi-exon organization, are dispersed mostly in the recombino-
genic subtelomeric regions of different chromosomes and, for the
most part, display mutually exclusive gene expression patterns. In
contrast, MSP3-family genes are structured as a single exon with a
contiguous organization on the same chromosome and impor-
Figure 6. Graphical presentation of antibody binding avidity against members of the MSP3-family of proteins under increasing
concentrations of NH4SCN. Shown here are two examples of affinity-purified antibodies Panel A: reactivity of anti-MSP3.4-Ct antibodies against
MSP3.1-Ct and Panel B: reactivity of anti-MSP3.7-Ct antibodies towards itself. The measure of antigen-antibody reactivity in absence of NH4SCN was
considered to be 100%, and the reactivity obtained in presence of increasing concentrations of NH4SCN was expressed as fractions of that 100%.
Since the antibody binding did not display a linear relationship with increasing concentrations of the chaotropic salt, antibody binding avidity was
determined by calculating the ‘% area covered by each curve’, as represented by the shaded area in the figure.
doi:10.1371/journal.pone.0005410.g006
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family also differs from other multi-gene families encoding for
merozoite secretory organelle proteins such as the RBL, EBL and
RAP that have multi-exon gene structure and exhibit considerable
variability in gene expression, as well as redundancy in
functionality [33–35]. Though members of other gene families
share a gene organization in common, throughout the family they
are usually quite diverse in their amino-acid sequences and the
resulting epitopes are generally not cross-reactive, except for the
rare exceptions [36]. For example, naturally occurring antibodies
against the EGF-like domains of different MSPs are not cross-
reactive [37,38]. In contrast, the C-terminal regions of the MSP3
family of proteins, while related in their overall organization,
exhibit intergenic diversity, but also contain polypeptide sequences
that generate shared or cross-reactive epitopes, which in contrast
with other multi-gene families are highly conserved across parasite
isolates.
Gene knockout approaches are currently considered as one
means to determine the functional importance of a given gene in
parasite biology. This was actually applied to several members of the
MSP3-family :DMSP3.1 [39] and DMSP3.2 (Mills & Cowman,
personal communication), DMSP3.3 and DMSP3.7 [31]. However, the
individual gene disruptions caused little or no effect on the in vitro
survival of mutant parasites. Perhaps one reason for these apparently
paradoxical findings may lie in the fact that all genes of the MSP3
family are transcribed together with the corresponding proteins
simultaneously expressed on the surface of P. falciparum merozoites.
Paralogous structures expressed by the remaining members of the
MSP3 family could thus compensate for the loss of either one
individually, providing the parasite with functional ‘‘spare-wheels’’,
whatever their as yet, undescribed biological function may be. On
the other hand, these paralogs except for their C-terminal regions
have radically different domain structures in the remainder of the
proteins implying, perhaps, differing functional roles for each. The
lack of an evident phenotype in vitro upon gene disruption may,
alternatively, imply that a phenotype can only be revealed in vivo
through host-parasite interactions, perhaps that involve the
‘conserved’ C-terminal domains.
Figure 7. Binding avidity study of antibody cross-reactivity observed amongst the related regions of the MSP3-family of proteins.
Antibody binding avidity for each antigen-antibody reaction is expressed in terms of ‘% area covered by the curve’ (as explained in the text and
Figure 6). Summing the binding avidities displayed by different antibody-preparations towards any given antigen provides an estimate of its
‘antigenicity’, obtained here along the columns. Similarly, summing the binding avidities displayed by any antibody-preparation towards different
antigens provides an estimate about the degree of ‘cross-reactivity’ for that antibody preparation, obtained here across the rows. Arranging the
molecules in the order of their increasing ‘antigenicity’ and the degree of ‘cross-reactivity’ displayed by affinity-purified antibodies shows MSP3.1-Ct
to be the most while MSP3.4-Ct being the least antigenic molecules in the family. Conversely, anti-MSP3.1-Ct antibodies displayed least cross-
reactivity in contrast to higher degree of cross-reactivity displayed by anti-MSP3.2-Ct and anti-MSP3.4-Ct antibodies.
doi:10.1371/journal.pone.0005410.g007
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were found to be targeted by antibodies that inhibit parasite
growth in cooperation with monocytes, with a magnitude similar
to the inhibition original found to be mediated by native
antibodies recognizing the MSP3.1 protein. This broadens the
scope of antigens involved in naturally acquired protection and
indicates that vaccine constructs based on them would likely be
valuable. Detailed analyses of MSP3.1, both on epidemiological
and clinical grounds as well as in assays reflecting antibody
mediated protection, led to the identification of three regions as
targets for protective antibodies [12]. The highest regions of
homology were found within these related C-terminal parts of the
Figure 8. Immunization in mice generates antibodies cross-reactive against the related regions of MSP3-family of proteins. Two
groups Balb/C mice (5 mice/group), were immunized with the related C-terminal recombinant proteins from MSP3.1 and MSP3.2, with montanide as
adjuvant. The histograms show mean O.D.450 values obtained for the reactivity of anti-MSP3.1-Ct and anti-MSP3.2-Ct mice sera against different
members of the MSP3-family of proteins. The error-bars represent s.d. values.
doi:10.1371/journal.pone.0005410.g008
Figure 9. Effect of human antibodies affinity-purified against the related C-terminal region of the MSP3 family of proteins on
parasite growth in ADCI assay. The histograms represent mean values of % SGI (as explained in the text) from two independent
experiments6standard error; values of .30% are significant. PIAG, positive control IgG from the pool of Ivory Coast adult sera used for passive
transfer in humans [6]. NIgG, negative control IgG from a pool of Caucasian adult sera, never exposed to malaria infection. Antibodies affinity purified
against two other malaria antigens RESA and AMA-I did not show significant parasite inhibition at the concentrations used in this assay.
doi:10.1371/journal.pone.0005410.g009
MSP3 Multigene Family
PLoS ONE | www.plosone.org 11 April 2009 | Volume 4 | Issue 4 | e5410MSP3 proteins, but the various MSP3 genes also showed
substantial diversity in sequence from one gene to the other.
The detailed antigenic analysis of the MSP3 family members
showed that, despite differences among their primary amino-acid
sequences, some epitopes and their antigenic properties are
sufficiently conserved to generate cross-reactive antibodies. The
extent of cross-reactivity is such that when an antibody response in
humans is detected against one member of the family these same
antibodies could have been elicited by any other member of the
multi-gene family. This results in a large network of reactivities for
each specific antibody across each of the members of the family;
certainly with demonstrable variations in regards to avidity.
Polymorphism in malaria parasite genes generated by random
mutations is a frequent characteristic of many genes coding for
antigens. This polymorphism is thought to have emerged under
selective immune pressure that frequently favors epitopic regions
involved in protection. Therefore, polymorphism selected by
immunity is considered a major bottleneck for vaccine develop-
ment that can lead to strain-specific protection or immune
evasion. This widely accepted notion differs markedly in the case
of the MSP3 multi-gene family as in this instance the evolutionary
drive responsible for sequence diversity cannot result from
immune selection of random mutations. Whereas the N-terminal
regions of these genes are highly divergent, the C-terminal
portions display limited sequence diversity between strains and
share high similarity in sequence and general structure as well as
antigenic characteristics. In addition, the full sequence conserva-
tion of the C-terminal regions of each member of the MSP3
family among distinct isolates, resulting in a conservation of
differences between genes, is striking and most unusual. We
speculate that in vivo the C-terminal parts of the proteins function
at the interface of the parasite with the immune responses of the
host. The anti-parasite effect of antibodies against each C-
terminal region together with the antigenic relatedness shared
between all members, suggests a minimal selective advantage to
random mutations, as antibodies generated against any one
member could still cross-react to other non-mutated member and
mediate parasite killing. In the context of a compromise between
the immunized host and infecting parasite, the nearly full
conservation of both the homology and diversity observed among
the C-terminal regions of the MSP3 family of proteins lead us to
raise two main hypotheses:
The first hypothesis is that this diversity generates a wider range
of antibody specificities reactive with the related members of an
antigenic network than would that of a single antigen. A wider
range of diversity in affinity, avidity and fine-specificity in the
antibody repertoire would result in reactivity to the wide range of
original and related epitopes and lead to greater efficacy of the
antibody mediated monocyte-dependent parasite killing.
The second hypothesis is that the differences in the sequence
also provide T-helper cell epitope diversity, resulting in the
induction of antibody responses in a wider range of human genetic
backgrounds, each gene sequence being better fitted to a given
MHC class-II subset. Hence, in this case, the conservation of
the diversity could provide T-cell help leading to the generation
of the same essential antibodies directed to the conserved cross-
reactive B-cell epitopes in most individuals. The results
obtained in a MSP3.1 vaccine trial are in support of this
hypothesis as not all volunteers immunized with only one
member of the family, MSP3.1, developed antibodies reactive
with native parasite proteins, whereas in endemic areas most
individuals develop antibodies to those main B-cell epitopes
[10,12,17,44].
These two hypotheses are not mutually exclusive, as the first one
concerns the regions of highest homology, the cross-reactive B-cell
epitopes, and the second the regions of greatest divergence among
the C-term regions, which were found to define T helper-cell
epitopes in MSP3.1. In both cases, the results point to the
production of anti-MSP3 cross-reactive antibodies that, by
triggering ADCI, have the ability to substantially control parasite
multiplication and in the process maintain low to moderate
parasite densities in the human host. This conservation of diversity
would also generate immune responses that can be thought of as
ensuring the ‘‘objective’’ of successful parasites; survival of both
the host and the parasite.
Our observations and findings enlarge the present perspectives
on the function of merozoite surface antigens and have
fundamental implications for the nature of the host-parasite
interaction, as may pertain to maintaining homeostasis between P.
falciparum and human beings. There may also be practical
consequences for vaccine development as our results suggest that
an improved MSP3 vaccine should combine the other various C-
terminus regions in the family in order to generate a wider range
of antibodies reacting with each of the various MSP3 family
antigens to improve the vaccine immunogenicity in humans across
most genetic backgrounds.
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